Expand ACET Menu
ACET MENU

ACET Latest Press Releases

-- September 30, 2026 --

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:12 PM

-- September 28, 2026 --

Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis Business Wire 6:45 AM

-- September 25, 2026 --

Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis Business Wire 4:00 PM

-- September 1, 2026 --

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update Business Wire 7:00 AM

-- August 31, 2026 --

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:39 PM

-- August 27, 2026 --

Adicet Bio Announces FDA Clearance of IND Application for ADI-212 Business Wire 4:00 PM

-- August 5, 2026 --

Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates Business Wire 4:15 PM

-- August 3, 2026 --

Lipocine Appoints Michael J. Grissinger to Board of Directors PRNewswire 8:00 AM

-- July 21, 2026 --

Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference Business Wire 4:00 PM

-- May 14, 2026 --

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference Business Wire 4:00 PM

-- May 13, 2026 --

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates Business Wire 4:01 PM
Market Data Delayed 15 Minutes